Cargando…

Correction: HDAC6 inhibitor WT161 downregulates growth factor receptors in breast cancer

Detalles Bibliográficos
Autores principales: Hideshima, Teru, Mazitschek, Ralph, Qi, Jun, Mimura, Naoya, Tseng, Jen-Chieh, Kung, Andrew L., Bradner, James E., Anderson, Kenneth C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8378766/
https://www.ncbi.nlm.nih.gov/pubmed/34434504
http://dx.doi.org/10.18632/oncotarget.28051
_version_ 1783740876602736640
author Hideshima, Teru
Mazitschek, Ralph
Qi, Jun
Mimura, Naoya
Tseng, Jen-Chieh
Kung, Andrew L.
Bradner, James E.
Anderson, Kenneth C.
author_facet Hideshima, Teru
Mazitschek, Ralph
Qi, Jun
Mimura, Naoya
Tseng, Jen-Chieh
Kung, Andrew L.
Bradner, James E.
Anderson, Kenneth C.
author_sort Hideshima, Teru
collection PubMed
description
format Online
Article
Text
id pubmed-8378766
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-83787662021-08-24 Correction: HDAC6 inhibitor WT161 downregulates growth factor receptors in breast cancer Hideshima, Teru Mazitschek, Ralph Qi, Jun Mimura, Naoya Tseng, Jen-Chieh Kung, Andrew L. Bradner, James E. Anderson, Kenneth C. Oncotarget Correction Impact Journals LLC 2021-08-17 /pmc/articles/PMC8378766/ /pubmed/34434504 http://dx.doi.org/10.18632/oncotarget.28051 Text en Copyright: © 2021 Hideshima et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/3.0/) (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Correction
Hideshima, Teru
Mazitschek, Ralph
Qi, Jun
Mimura, Naoya
Tseng, Jen-Chieh
Kung, Andrew L.
Bradner, James E.
Anderson, Kenneth C.
Correction: HDAC6 inhibitor WT161 downregulates growth factor receptors in breast cancer
title Correction: HDAC6 inhibitor WT161 downregulates growth factor receptors in breast cancer
title_full Correction: HDAC6 inhibitor WT161 downregulates growth factor receptors in breast cancer
title_fullStr Correction: HDAC6 inhibitor WT161 downregulates growth factor receptors in breast cancer
title_full_unstemmed Correction: HDAC6 inhibitor WT161 downregulates growth factor receptors in breast cancer
title_short Correction: HDAC6 inhibitor WT161 downregulates growth factor receptors in breast cancer
title_sort correction: hdac6 inhibitor wt161 downregulates growth factor receptors in breast cancer
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8378766/
https://www.ncbi.nlm.nih.gov/pubmed/34434504
http://dx.doi.org/10.18632/oncotarget.28051
work_keys_str_mv AT hideshimateru correctionhdac6inhibitorwt161downregulatesgrowthfactorreceptorsinbreastcancer
AT mazitschekralph correctionhdac6inhibitorwt161downregulatesgrowthfactorreceptorsinbreastcancer
AT qijun correctionhdac6inhibitorwt161downregulatesgrowthfactorreceptorsinbreastcancer
AT mimuranaoya correctionhdac6inhibitorwt161downregulatesgrowthfactorreceptorsinbreastcancer
AT tsengjenchieh correctionhdac6inhibitorwt161downregulatesgrowthfactorreceptorsinbreastcancer
AT kungandrewl correctionhdac6inhibitorwt161downregulatesgrowthfactorreceptorsinbreastcancer
AT bradnerjamese correctionhdac6inhibitorwt161downregulatesgrowthfactorreceptorsinbreastcancer
AT andersonkennethc correctionhdac6inhibitorwt161downregulatesgrowthfactorreceptorsinbreastcancer